| Early regenerative capacity in the porcine heart L Ye, G D’Agostino, SJ Loo, CX Wang, LP Su, SH Tan, GZ Tee, CJ Pua, ... Circulation 138 (24), 2798-2808, 2018 | 260 | 2018 |
| Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis B Ng, J Dong, G D’Agostino, S Viswanathan, AA Widjaja, WW Lim, ... Science translational medicine 11 (511), eaaw1237, 2019 | 253 | 2019 |
| Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis AA Widjaja, BK Singh, E Adami, S Viswanathan, J Dong, GA D’Agostino, ... Gastroenterology 157 (3), 777-792. e14, 2019 | 252 | 2019 |
| TRIC: an automated alignment strategy for reproducible protein quantification in targeted proteomics HL Röst, Y Liu, G D'Agostino, M Zanella, P Navarro, G Rosenberger, ... Nature methods 13 (9), 777-783, 2016 | 194 | 2016 |
| The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) M Scorsetti, T Comito, L Cozzi, E Clerici, A Tozzi, C Franzese, P Navarria, ... Journal of cancer research and clinical oncology 141, 1301-1309, 2015 | 187 | 2015 |
| Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin G Scambia, R De Vincenzo, PO Ranelletti, PB Panici, G Ferrandina, ... European Journal of Cancer 32 (5), 877-882, 1996 | 187 | 1996 |
| 7q11. 23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages A Adamo, S Atashpaz, PL Germain, M Zanella, G D'Agostino, V Albertin, ... Nature genetics 47 (2), 132-141, 2015 | 173 | 2015 |
| Survival after radiotherapy in gastric cancer: systematic review and meta-analysis V Valentini, F Cellini, BD Minsky, GC Mattiucci, M Balducci, G D’Agostino, ... Radiotherapy and oncology 92 (2), 176-183, 2009 | 157 | 2009 |
| Potassium channel dysfunction in human neuronal models of Angelman syndrome AX Sun, Q Yuan, M Fukuda, W Yu, H Yan, GGY Lim, MH Nai, ... Science 366 (6472), 1486-1492, 2019 | 156 | 2019 |
| A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer G D'agostino, J Del Campo, B Mellado, MA Izquierdo, T Minarik, L Cirri, ... International Journal of Gynecological Cancer 16 (1), 71-76, 2006 | 120 | 2006 |
| Widespread translational control of fibrosis in the human heart by RNA-binding proteins S Chothani, S Schäfer, E Adami, S Viswanathan, AA Widjaja, SR Langley, ... Circulation 140 (11), 937-951, 2019 | 119 | 2019 |
| Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer G D’Agostino, F Amant, P Berteloot, G Scambia, I Vergote Gynecologic oncology 88 (3), 266-269, 2003 | 115 | 2003 |
| The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes M Gabriele, AL Tobon, G D'Agostino, G Testa Progress in Neuro-Psychopharmacology and Biological Psychiatry 84, 306-327, 2018 | 112 | 2018 |
| Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience V Valentini, F Calvo, M Reni, R Krempien, F Sedlmayer, MW Buchler, ... Radiotherapy and Oncology 91 (1), 54-59, 2009 | 103 | 2009 |
| Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma P Navarria, AM Ascolese, L Cozzi, S Tomatis, GR D’Agostino, F De Rose, ... European Journal of Cancer 51 (5), 668-674, 2015 | 101 | 2015 |
| Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study T Comito, L Cozzi, E Clerici, C Franzese, A Tozzi, C Iftode, P Navarria, ... Technology in cancer research & treatment 16 (3), 295-301, 2017 | 99 | 2017 |
| A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 study): a collaboration of … G Macchia, R Lazzari, N Colombo, C Laliscia, G Capelli, GR D'Agostino, ... The oncologist 25 (2), e311-e320, 2020 | 87 | 2020 |
| Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection P Navarria, F Pessina, L Cozzi, AM Ascolese, F De Rose, A Fogliata, ... Radiation Oncology 11, 1-10, 2016 | 84 | 2016 |
| An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease F Lescai, AM Chiamenti, A Codemo, C Pirazzini, G D'Agostino, C Ruaro, ... Journal of Alzheimer's Disease 24 (2), 235-245, 2011 | 79 | 2011 |
| Stereotactic body radiation therapy: a promising chance for oligometastatic breast cancer M Scorsetti, D Franceschini, F De Rose, T Comito, E Villa, C Iftode, ... The Breast 26, 11-17, 2016 | 76 | 2016 |
